You are here: Industry Insights > COVID-19

News List

Pluristem forms Covid-19 drug development alliance pharmaceutical-technology
March 16, 2020
Israel-based Pluristem Therapeutics has collaborated with the BIH Center for Regenerative Therapy (BCRT) and the Berlin Center for Advanced Therapies (BeCAT) ...
Advaite Produces COVID-19 Rapid Response Diagnostic Kits contractpharma
March 16, 2020
Diagnostic testing kit, ADVAITE RAPCOV, has ability to provide results in 15-30 minutes from a drop of fingertip blood and offers a solution for mass screening.
AbCellera, Lilly Partner to Develop Antibodies Against COVID-19 contractpharma
March 16, 2020
Will leverage AbCellera's rapid pandemic response platform and Lilly's global development, manufacturing and distribution capabilities.
Biogen, Vir Enter COVID-19 Antibody Alliance contractpharma
March 16, 2020
Biogen will provide cell line development, process development and clinical manufacturing for Vir's monoclonal antibodies.
Gilead's Remdesivir Shows Promise in COVID-19 contractpharma
March 16, 2020
According to a World Health Organizationofficial, Gilead's experimental antiviral drug remdesivir, to date, shows the most promise for treating COVID-19 disease.
BeyondSpring Files for Patent Protection for Viral Infections Treatment americanpharmaceuticalreview
March 16, 2020
BeyondSpring announced the submission of a provisional U.S. patent application for its pipeline asset BPI-002, for methods of treating viral infections, including COVID-19 ...
FDA Provides Surgical Mask, Gown Conservation Strategies americanpharmaceuticalreview
March 16, 2020
The U.S. Food and Drug Administration (FDA) recognizes that the need for personal protective equipment (PPE), such as surgical masks, surgical and isolation gowns, and surgical suits ...
I-Mab to Develop TJM2 for Cytokine Release Syndrome Patients with COVID-19 americanpharmaceuticalreview
March 16, 2020
I-Mab Biopharma is initiating the development of TJM2 (TJ003234) to treat cytokine storm in severe and critically ill patients caused by the coronavirus disease (COVID-19).
Elsevier Gives Full Access to its Content on its COVID-19 Information Center for PubMed Central and Other Public Health Databases to Accelerate Fight Against Coronavirus PRNewswire
March 16, 2020
Elsevier is making all its research and data content on its COVID-19 Information Center available to PubMed Central, the archive of biomedical and lifescience at the US National Institutes of Health's National Library of Medicine, and the other publicly f
International Psoriasis Council Statement On The Coronavirus (COVID-19) Outbreak prnasia
March 14, 2020
The rapid spread of the coronavirus (COVID-19) is a serious public health concern. It remains unknown to what extent the coronavirus impacts psoriasis and the treatment of psoriasis.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page